Managing Facial Hyperpigmentation

Abstract

This JAMA Network Insight describes dermatologists’ role in managing hyperpigmentation, from counseling on photoprotection to prescribing treatment regimens, for this psychosocially distressing entity.

Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation—Reply

“…In Reply We thank Hashemi et al for their engagement and thoughtful reply to our article that highlighted their experience with tranexamic acid (TA) and procedural therapies. We agree that treatment approaches in hyperpigmentation have had great advancements.…”

“…We agree that treatment approaches in hyperpigmentation have had great advancements. We also recognize that tranexamic acid offers an additional option for treating melasma, as we discussed in our article . However, more guidance is needed on optimal therapeutic ranges, dosing regimens, length of treatment, and effects on certain patient populations, such as those receiving hormonal treatments and/or with hypercoagulable disorders.…”

Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation

“…To the Editor In reading the recent article by Kundu et al 1 regarding the management of facial hyperpigmentation due to melasma and postinflammatory hyperpigmentation (PIH), we have additional perspectives regarding medical and procedural management given recent advancements described in the literature and our own clinical experience. Regarding medical management, several recent studies have supported the effectiveness and safety of oral tranexamic acid (TA) in treating various pigmentary disorders, such as melasma and PIH.…”